PlentiPlex™ MYD88 Waldenström 淋巴瘤 qPCR 分析:检测 MYD88 L265P 突变的高灵敏度方法。

IF 2.2 4区 医学 Q3 HEMATOLOGY
Marcello Viscovo, Mia de Laurent Clemmensen, Federica Fosso, Elena Maiolo, Francesco Autore, Luca Laurenti, Stefan Hohaus, Patrizia Chiusolo
{"title":"PlentiPlex™ MYD88 Waldenström 淋巴瘤 qPCR 分析:检测 MYD88 L265P 突变的高灵敏度方法。","authors":"Marcello Viscovo,&nbsp;Mia de Laurent Clemmensen,&nbsp;Federica Fosso,&nbsp;Elena Maiolo,&nbsp;Francesco Autore,&nbsp;Luca Laurenti,&nbsp;Stefan Hohaus,&nbsp;Patrizia Chiusolo","doi":"10.1111/ijlh.14255","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Agarose gel-based conventional and real-time allele-specific polymerase chain reaction (AS-PCR) assays are currently used for sensitive detection and quantification of <i>MYD88</i> L265P mutation. Visual inspection of an agarose gel can often be ambiguous. We propose a new allele-specific quantification PCR (AS-qPCR) assay, PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay, that uses Intercalating Nucleic Acid (INA®) technology for increased affinity and specificity.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>This study compares PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay with conventional AS-PCR. We included a total of 102 peripheral and bone marrow blood samples from 94 patients with a lymphoproliferative disorder. Droplet digital PCR (ddPCR) was used as a third method in case of discrepancy.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A positive percent agreement of 100% (95% CI 0.92–1.0) and a negative percent agreement of 98% (95% CI 0.90–1.0) were found between the conventional AS-PCR and the AS-qPCR methods. Including the ddPCR results to validate the discrepant cases, the sensitivity and specificity of PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR Assay were 1.0 (95% CI 0.97–1.0) and 1.0 (95% CI 0.96–1.0), respectively.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our data demonstrate that PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay is a fast, highly sensitive, and specific method for the detection of <i>MYD</i>88 L265P compared with conventional AS-PCR.</p>\n </section>\n </div>","PeriodicalId":14120,"journal":{"name":"International Journal of Laboratory Hematology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation\",\"authors\":\"Marcello Viscovo,&nbsp;Mia de Laurent Clemmensen,&nbsp;Federica Fosso,&nbsp;Elena Maiolo,&nbsp;Francesco Autore,&nbsp;Luca Laurenti,&nbsp;Stefan Hohaus,&nbsp;Patrizia Chiusolo\",\"doi\":\"10.1111/ijlh.14255\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Agarose gel-based conventional and real-time allele-specific polymerase chain reaction (AS-PCR) assays are currently used for sensitive detection and quantification of <i>MYD88</i> L265P mutation. Visual inspection of an agarose gel can often be ambiguous. We propose a new allele-specific quantification PCR (AS-qPCR) assay, PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay, that uses Intercalating Nucleic Acid (INA®) technology for increased affinity and specificity.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>This study compares PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay with conventional AS-PCR. We included a total of 102 peripheral and bone marrow blood samples from 94 patients with a lymphoproliferative disorder. Droplet digital PCR (ddPCR) was used as a third method in case of discrepancy.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A positive percent agreement of 100% (95% CI 0.92–1.0) and a negative percent agreement of 98% (95% CI 0.90–1.0) were found between the conventional AS-PCR and the AS-qPCR methods. Including the ddPCR results to validate the discrepant cases, the sensitivity and specificity of PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR Assay were 1.0 (95% CI 0.97–1.0) and 1.0 (95% CI 0.96–1.0), respectively.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our data demonstrate that PlentiPlex™ <i>MYD</i>88 Waldenström lymphoma qPCR assay is a fast, highly sensitive, and specific method for the detection of <i>MYD</i>88 L265P compared with conventional AS-PCR.</p>\\n </section>\\n </div>\",\"PeriodicalId\":14120,\"journal\":{\"name\":\"International Journal of Laboratory Hematology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-02-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Laboratory Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/ijlh.14255\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Laboratory Hematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ijlh.14255","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:目前,基于琼脂糖凝胶的传统和实时等位基因特异性聚合酶链反应(AS-PCR)测定法被用于灵敏检测和定量 MYD88 L265P 突变。肉眼观察琼脂糖凝胶往往会产生模糊不清的感觉。我们提出了一种新的等位基因特异性定量 PCR(AS-qPCR)检测方法--PlentiPlex™ MYD88 Waldenström 淋巴瘤 qPCR 检测方法,该方法采用互锁核酸(INA®)技术,提高了亲和力和特异性:本研究比较了 PlentiPlex™ MYD88 Waldenström 淋巴瘤 qPCR 检测法和传统的 AS-PCR。我们共采集了 94 名淋巴细胞增生性疾病患者的 102 份外周血和骨髓血样本。液滴数字 PCR(ddPCR)被用作第三种方法,以防出现差异:结果:传统的 AS-PCR 和 AS-qPCR 方法的阳性一致率为 100%(95% CI 0.92-1.0),阴性一致率为 98%(95% CI 0.90-1.0)。包括验证差异病例的 ddPCR 结果在内,PlentiPlex™ MYD88 沃登斯特伦淋巴瘤 qPCR 检测法的灵敏度和特异性分别为 1.0(95% CI 0.97-1.0)和 1.0(95% CI 0.96-1.0):我们的数据表明,与传统的 AS-PCR 相比,PlentiPlex™ MYD88 Waldenström 淋巴瘤 qPCR 检测是一种快速、高灵敏度和特异性的 MYD88 L265P 检测方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay: A highly sensitive method for detection of MYD88 L265P mutation

Introduction

Agarose gel-based conventional and real-time allele-specific polymerase chain reaction (AS-PCR) assays are currently used for sensitive detection and quantification of MYD88 L265P mutation. Visual inspection of an agarose gel can often be ambiguous. We propose a new allele-specific quantification PCR (AS-qPCR) assay, PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay, that uses Intercalating Nucleic Acid (INA®) technology for increased affinity and specificity.

Methods

This study compares PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay with conventional AS-PCR. We included a total of 102 peripheral and bone marrow blood samples from 94 patients with a lymphoproliferative disorder. Droplet digital PCR (ddPCR) was used as a third method in case of discrepancy.

Results

A positive percent agreement of 100% (95% CI 0.92–1.0) and a negative percent agreement of 98% (95% CI 0.90–1.0) were found between the conventional AS-PCR and the AS-qPCR methods. Including the ddPCR results to validate the discrepant cases, the sensitivity and specificity of PlentiPlex™ MYD88 Waldenström lymphoma qPCR Assay were 1.0 (95% CI 0.97–1.0) and 1.0 (95% CI 0.96–1.0), respectively.

Conclusion

Our data demonstrate that PlentiPlex™ MYD88 Waldenström lymphoma qPCR assay is a fast, highly sensitive, and specific method for the detection of MYD88 L265P compared with conventional AS-PCR.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.50
自引率
6.70%
发文量
211
审稿时长
6-12 weeks
期刊介绍: The International Journal of Laboratory Hematology provides a forum for the communication of new developments, research topics and the practice of laboratory haematology. The journal publishes invited reviews, full length original articles, and correspondence. The International Journal of Laboratory Hematology is the official journal of the International Society for Laboratory Hematology, which addresses the following sub-disciplines: cellular analysis, flow cytometry, haemostasis and thrombosis, molecular diagnostics, haematology informatics, haemoglobinopathies, point of care testing, standards and guidelines. The journal was launched in 2006 as the successor to Clinical and Laboratory Hematology, which was first published in 1979. An active and positive editorial policy ensures that work of a high scientific standard is reported, in order to bridge the gap between practical and academic aspects of laboratory haematology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信